Shefali Agarwal

Companies

• Fate TherapeuticsBoard member Jul 17, 2019 to now¹
• Gritstone bio, Inc.Board member Nov 19, 2021 to Apr 8, 2025²
• Epizyme, Inc.Chief Medical Officer Jul 24, 2018 to Mar 21, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• FTFate Therapeutics FATE10,490 shares⁴$18.8K at $1.79Jun 9, 2022
• EEpizyme, Inc.0 shares⁵Aug 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 12, 2022Returned to company 107,292 shares of Epizyme, Inc.⁵
• Aug 12, 2022Returned to company 179,247 shares of Epizyme, Inc.⁵
• Aug 9, 2022Shares withheld for tax 373,154 shares at $1.39 of Epizyme, Inc.⁶
• Aug 9, 2022Exercised options 400,000 shares at $1.39 of Epizyme, Inc.⁶
• Aug 9, 2022Exercised options 43,473 shares at $1.39 of Epizyme, Inc.⁶
• Aug 9, 2022Exercised options 56,527 shares at $1.39 of Epizyme, Inc.⁶
• Jun 9, 2022Granted 8,650 shares of Fate Therapeutics⁴
• Jun 7, 2022Sold 841 shares at $21.89 of Fate Therapeutics⁷
• Jun 3, 2022Sold of Fate Therapeutics⁸
• Jun 3, 2022Sold 807 shares at $22.80 of Fate Therapeutics⁹
• Feb 28, 2022Granted 2,331 shares at $1.27 of Epizyme, Inc.¹⁰
• Feb 7, 2022Sold 1,058 shares at $1.50 of Epizyme, Inc.¹¹
• Feb 2, 2022Sold 2,639 shares at $1.37 of Epizyme, Inc.¹²
• Jan 26, 2022Sold 2,922 shares at $2.02 of Epizyme, Inc.¹³
• Dec 6, 2021Sold 1,780 shares at $2.93 of Epizyme, Inc.¹⁴